RACE Trial

Main Content

Trial Resources

Below are resources related to the project that you may find useful.

Clinical trial registration

The RACE trial is a registered clinical trial on www.clinicaltrials.gov identifier: NCT01665092. The direct link to the trial registration is http://clinicaltrials.gov/ct2/show/NCT01665092?term=RACE&rank=6


The major research network administering RACE is EMSHOCKNET. The Emergency Medicine Shock Research Network is a US research network focusing on clinical issues related to the pathophysiology, diagnosis, risk-stratification, and treatment of various forms of shock, particularly septic shock and undifferentiated shock. It is comprised primarily of emergency and critical care physicians and the major activity of this network is conducting large multi-center observational and interventional research studies.

The mission of EM Shock Net is to improve the care of critically ill and injured patients primarily through research innovations. The majority of the research conducted by the Network takes place in emergency departments and intensive care units in acutely ill patient populations.

Berry Consultants

Berry Consultants is a statistical consulting group specializing in adaptive clinical trial design in pharmaceutical and medical device research and development. They are leaders in the Bayesian approach to medical statistics. This approach is radically changing the way research is done throughout the medical industry (device and drug development). They employ world renown experts in Bayesian statistics and strive to set the standard for Bayesian design and analysis in the statistical and medical communities.


The mission of the National Institute of General Medical Sciences (NIGMS) is to support research that increases understanding of life processes and lays the foundation for advances in disease diagnosis, treatment and prevention. NIGMS-funded researchers seek to answer important scientific questions in fields such as cell biology, biophysics, genetics,developmental biology, pharmacology, physiology, biological chemistry, biomedical technology, bioinformatics, computational biology, selected aspects of the behavioral sciences and specific cross-cutting clinical areas that affect multiple organ systems. To assure the vitality and continued productivity of the research enterprise, NIGMS also provides leadership in training the next generation of scientists as well as in developing and increasing the diversity of the scientific workforce.